[A survey on French hospital physicians'certification to the good clinical practices].

Enquête sur la certification aux bonnes pratiques cliniques en recherche académique.
Bonnes pratiques cliniques Certification Clinical trial Essais cliniques Formation Good clinical practices Investigateur Investigator Promotion Sponsoring Training

Journal

Therapie
ISSN: 1958-5578
Titre abrégé: Therapie
Pays: France
ID NLM: 0420544

Informations de publication

Date de publication:
Historique:
received: 02 10 2019
revised: 28 01 2020
accepted: 09 04 2020
pubmed: 16 5 2020
medline: 18 9 2021
entrez: 16 5 2020
Statut: ppublish

Résumé

Good clinical practice (GCP) is an international ethical and scientific quality standard for the design, conduct, performance, monitoring, auditing, recording, analyses and reporting of clinical trials. Before the start of a clinical trial, investigators commit to perform the research in accordance with GCPs, regulatory dispositions and protocol. The sponsors are responsible for investigators' selection and for controlling their skills. Whereas industrial sponsors systematically require a certificate of GCP training, academic sponsors seem to be less demanding. We have carried out two surveys between April and June 2018. A first questionnaire was sent to the 40 French academic directions of clinical research and innovation in order to determine their requirements about the GCP training of the investigators participating in their trials. The second questionnaire was transmitted to physicians of the "Bretagne recherche clinique hospitalière network": Rennes, Saint-Malo, Saint-Brieuc, Vannes, Lorient and Pontivy hospitals, in order to determine the GCP certification rate, and their needs in terms of clinical research training. Twenty-eight (70%) directions of clinical research answered the first survey, among which 18 (64%) required systematically the investigators' GCP certification in case of category 1 interventional studies. This rate decreased for category 2 (50%) and non-interventional category 3 (18%) studies. A total of 345 physicians answered the second survey, among which 263 (76%) had already been clinical trial investigators. However, only 29% of all physicians and 54% of those who had been principal investigator were certified for GCP training. These results support the need for large campaigns of GCP training in public hospitals.

Identifiants

pubmed: 32409207
pii: S0040-5957(20)30066-4
doi: 10.1016/j.therap.2020.04.002
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

537-542

Informations de copyright

Copyright © 2020 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Claire Fougerou-Leurent (C)

Service de pharmacologie clinique, CHU de Rennes, 35000 Rennes, France; CIC 1414, Inserm, centre d'investigation clinique de Rennes, 35000 Rennes, France. Electronic address: claire.fougerou@chu-rennes.fr.

Jimmy Chesnais (J)

Service de pharmacologie clinique, CHU de Rennes, 35000 Rennes, France; CIC 1414, Inserm, centre d'investigation clinique de Rennes, 35000 Rennes, France.

Sabrina Nekmouche (S)

Service de pharmacologie clinique, CHU de Rennes, 35000 Rennes, France; CIC 1414, Inserm, centre d'investigation clinique de Rennes, 35000 Rennes, France.

Aurélie Veislinger (A)

Service de pharmacologie clinique, CHU de Rennes, 35000 Rennes, France; CIC 1414, Inserm, centre d'investigation clinique de Rennes, 35000 Rennes, France.

Mariella Le Saux (M)

Unité de recherche clinique, centre hospitalier de Lorient, 56322 Lorient, France.

Céline Joumard (C)

Centre de recherche clinique, centre hospitalier de Bretagne Atlantique, 56017 Vannes, France.

Véronique Lorre (V)

Institut de formation des professionnels de santé, 56017 Vannes, France.

Catherine Bellot (C)

Unité de recherche clinique, centre hospitalier de Saint-Brieuc, 22000 Saint-Brieuc, France.

Nathalie Alleton (N)

Unité de recherche clinique, CHSP Guillaume Régnier, 35700 Rennes, France.

Elodie Labourdette (E)

Unité de recherche clinique, centre hospitalier de Saint-Malo, 35400 Saint-Malo, France.

Carole Marie (C)

Direction des affaires médicales, centre hospitalier de Centre Bretagne, 56920 Noyal-Pontivy, France.

Loïc Fin (L)

Direction de la recherche clinique, CHU de Rennes, 35000 Rennes, France.

Eric Bellissant (E)

Service de pharmacologie clinique, CHU de Rennes, 35000 Rennes, France; CIC 1414, Inserm, centre d'investigation clinique de Rennes, 35000 Rennes, France; Université Rennes, 35000 Rennes, France.

Bruno Laviolle (B)

Service de pharmacologie clinique, CHU de Rennes, 35000 Rennes, France; CIC 1414, Inserm, centre d'investigation clinique de Rennes, 35000 Rennes, France; Université Rennes, 35000 Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH